Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you
Mutualfunds logo

ETGLX Eventide Gilead N

  • Fund
  • ETGLX
  • Price as of: Dec 12, 2018
  • $35.66
  • + $0.43
  • + 1.22%
  • Category
  • Mid Cap Growth Equities

ETGLX - Profile

Vitals

  • YTD Return 4.1%
  • 3 Yr Annualized Return 12.0%
  • 5 Yr Annualized Return 10.8%
  • Net Assets $1.96 B
  • Holdings in Top 10 29.3%

52 WEEK LOW AND HIGH

$35.66
$33.53
$40.62

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.39%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 24.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

STANDARD (TAXABLE)

$1,000

IRA

$1,000

Investment Themes

CATEGORY

Mid Cap Growth Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Mid-Cap Growth

Distributions

  • YTD Total Return 4.1%
  • 3 Yr Annualized Total Return 12.0%
  • 5 Yr Annualized Total Return 10.8%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.16%
DIVIDENDS
  • Dividend Yield N/A
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name Eventide Gilead Fund
  • Fund Family Name Eventide Funds
  • Inception Date Jul 01, 2008
  • Shares Outstanding N/A
  • Share Class N
  • Currency USD
  • Domiciled Country United States
  • Manager Finny Kuruvilla

ETGLX - Performance

Return Ranking - Trailing

Period ETGLX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 4.1% -98.2% 941.3% 17.17% 1
1 Yr 11.1% -20.6% 34.6% 20.18% 2
3 Yr 12.0% * -5.9% 28.7% 22.63% 2
5 Yr 10.8% * -1.3% 17.6% 19.71% 1
10 Yr 18.6% * 2.0% 21.7% 1.09% 1

* Annualized


Return Ranking - Calendar

Period ETGLX Return Category Return Low Category Return High Rank in Category (%) Quintile
2017 32.9% -70.5% 158.6% 2.02% 1
2016 0.9% -61.7% 27.9% 49.60% 3
2015 -3.3% -82.5% 31.3% 25.85% 2
2014 17.7% -29.3% 35.0% 3.87% 1
2013 51.8% -27.0% 200.0% 0.73% 1

Total Return Ranking - Trailing

Period ETGLX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 4.1% -100.0% 941.3% 17.27% 1
1 Yr 11.1% -35.2% 876.4% 17.72% 1
3 Yr 12.0% * -5.2% 23.6% 19.52% 1
5 Yr 10.8% * -1.7% 17.4% 18.08% 1
10 Yr 18.6% * 2.0% 21.7% 1.09% 1

* Annualized


Total Return Ranking - Calendar

Period ETGLX Return Category Return Low Category Return High Rank in Category (%) Quintile
2017 32.9% -98.2% 158.6% 2.03% 1
2016 0.9% -61.7% 27.9% 55.14% 3
2015 -2.2% -43.1% 62.9% 61.07% 4
2014 18.1% -23.5% 561.9% 7.91% 1
2013 54.7% -22.5% 382.6% 35.41% 2

NAV & Total Return History

ETGLX - Holdings

Filings data as of: Sep 30, 2018

Concentration Analysis

ETGLX Category Low Category High ETGLX % Rank Quintile
Net Assets 1.96 B 281 K 30.1 B 9.21% 2
Number of Holdings 65 3 2254 12.78% 4
Net Assets in Top 10 624 M 84.9 K 5.92 B 6.69% 2
Weighting of Top 10 29.3% 6.2% 100.0% 13.37% 2

Top 10 Holdings

  1. Lowe's Companies Inc 3.05%
  2. XPO Logistics Inc 4.22%
  3. Wayfair Inc Class A 2.77%
  4. Ascendis Pharma A/S ADR 3.32%
  5. Splunk Inc 2.57%
  6. HubSpot Inc 2.48%
  7. SendGrid Inc 3.40%
  8. The Trade Desk Inc A 2.55%
  9. Varonis Systems Inc 2.51%
  10. Sarepta Therapeutics Inc 2.41%

Asset Allocation

Weighting Category Low Category High ETGLX % Rank Quintile
Stocks
84.07% 11.70% 120.97% 31.05% 5
Cash
14.59% -20.98% 41.42% 1.49% 1
Other
1.34% -11.12% 79.22% 2.97% 1
Preferred Stocks
0.00% 0.00% 7.47% 3.57% 4
Convertible Bonds
0.00% 0.00% 1.94% 0.74% 4
Bonds
0.00% 0.00% 67.65% 2.23% 4

Stock Sector Breakdown

Weighting Category Low Category High ETGLX % Rank Quintile
Technology
28.03% 0.00% 59.40% 9.36% 2
Healthcare
20.87% 0.00% 33.97% 3.27% 1
Consumer Cyclical
12.73% 0.00% 52.82% 25.41% 4
Industrials
11.50% 0.00% 39.08% 30.01% 5
Utilities
3.29% 0.00% 11.10% 2.97% 1
Basic Materials
2.69% 0.00% 17.10% 17.53% 3
Real Estate
2.53% 0.00% 46.47% 16.94% 3
Consumer Defense
1.48% 0.00% 22.39% 29.12% 5
Communication Services
0.90% 0.00% 16.81% 15.45% 3
Financial Services
0.00% -0.52% 47.49% 35.81% 5
Energy
0.00% 0.00% 14.82% 26.60% 5

Stock Geographic Breakdown

Weighting Category Low Category High ETGLX % Rank Quintile
US
75.04% 11.49% 115.87% 33.43% 5
Non US
9.03% 0.00% 41.39% 4.90% 1

ETGLX - Expenses

Operational Fees

ETGLX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 1.39% 0.07% 111.05% 19.08% 3
Management Fee 1.00% 0.06% 1.50% 0.89% 5
12b-1 Fee 0.20% 0.00% 1.00% 3.20% 2
Administrative Fee 0.10% 0.00% 25000.00% 5.31% 3

Sales Fees

ETGLX Fees (% of AUM) Category Low Category High ETGLX Rank Quintile
Front Load N/A 0.00% 5.75% N/A N/A
Deferred Load N/A 1.00% 5.50% N/A N/A

Trading Fees

ETGLX Fees (% of AUM) Category Low Category High ETGLX Rank Quintile
Max Redemption Fee N/A 0.05% 2.00% N/A N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

ETGLX Fees (% of AUM) Category Low Category High ETGLX Rank Quintile
Turnover 24.00% 0.00% 495.00% 19.82% 2

ETGLX - Distributions

Dividend Yield Analysis

ETGLX Category Low Category High ETGLX % Rank Quintile
Dividend Yield N/A 0.00% 2.73% N/A N/A

Dividend Distribution Analysis

ETGLX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Monthly Annually

Net Income Ratio Analysis

ETGLX Category Low Category High ETGLX % Rank Quintile
Net Income Ratio -0.16% -2.55% 4.79% 13.26% 2

Capital Gain Distribution Analysis

ETGLX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

ETGLX - Managers

Finny Kuruvilla

Lead Manager

Start Date

Jul 01, 2008

Tenure

10.42

Tenure Rank

7.4%

Finny Kuruvilla, M.D., Ph.D. Dr. Kuruvilla has been the Managing Partner of Eventide Asset Management, LLC since its inception in 2008. Dr. Kuruvilla possesses a diverse background in quantitative methods, with applications focused on innovations in science, engineering, and medicine. He holds an MD from Harvard Medical School, a PhD in Chemistry and Chemical Biology from Harvard University, a master’s degree in Electrical Engineering and Computer Science from MIT, and a bachelor’s degree from Caltech in Chemistry. From 2005-2008, Dr. Kuruvilla was a clinical fellow at the Brigham and Women's Hospital and a postdoctoral scientist at MIT. As an avid proponent of values-based investing, Dr. Kuruvilla has established rigorous standards in seeking out the most ethical companies at the outset of the stock selection process. In addition to his duties as the Fund’s portfolio manager, Dr. Kuruvilla has also been a Principal at Clarus Ventures since 2008. From 2006-2008, Dr. Kuruvilla was a research fellow at the Broad Institute of Harvard and MIT.


Tenure Analysis

Category Low

0.0

Category High

32.7

Category Average

7.92

Category Mode

0.5